At AIMSMEDICAL™, we are a leading provider in the medical diagnostic field. Our ultimate goal is to transform how healthcare providers approach the screening and monitoring of conditions related to aging, such as oropharyngeal dysphagia, using our artificial intelligence-powered technology platform to enable quicker and more efficient patient assessment and care prioritization.

AIMSMEDICAL™ can provide your company with medical diagnostic services as well as assistance and consulting related to all your Software as a Service needs. Call us now to learn more.

2025 | June

Cristina Amadó, Industrial PhD candidate at AIMS MEDICAL, presented two AI-driven studies at the THAIS 2025 symposium in Sabadell, focused on dysphagia screening and aspiration pneumonia detection.
Her work highlights the potential of AIMS-OD algorithms to improve diagnosis in older patients and support safer, smarter clinical decision-making.
Learn more about what this recognition means for AIMS MEDICAL in our news article [here]

2025 | March

AIMS MEDICAL triumphs at 4YFN 2025: Winner of the University & Spin-off Programme: Spin-off Pitch Battle, reinforcing our commitment to healthcare innovation.
Competing among the best: Faced top university spin-offs and pitched to leading investors from ROI Ventures, LG Tech Ventures, and SpeedInvest.
A step forward in healthcare technology: This achievement fuels our mission to develop cutting-edge solutions that make a real impact.

2025 | March

Strong presence at 4YFN 2025: AIMS MEDICAL showcased its vision for healthcare innovation, networking with industry leaders and investors at its stand alongside TecnoCampus.
Keynote participation & networking: Natalia Estrada Barreras presented at XarSmart and the CataloniaHealthInnovation Pavilion, highlighting our approach to scaling digital health spin-offs.
Gratitude & future outlook: Thanks to our partners and TecnoCampus for their support—this experience fuels our mission to drive innovation in healthcare technology.
For more information, you can read the full article [here]

2024 | October

AIMS MEDICAL participated in the 34th Barcelona Healthcare Investment Forum, hosted by the Official College of Physicians of Barcelona. OurCEO, Neus Giménez, presented the company’s mission to reduce the under-diagnosis of oropharyngeal dysphagia in Europe, where 80% of the 30 million cases go undiagnosed.
AIMS-OD, a software as a service, enabling rapid, large-scale screening, is already being piloted in Catalan public hospitals through CatSalut’s Transforming Projects. AIMS MEDICAL is now seeking seed funding to expand globally and bring this innovative solution to market.
For more information, you can read the full article [here]

2024 | October

AIMS MEDICAL welcomed the co-founders of Scicake at our Tecnocampus office on October 24th to explore potential collaborations in healthcare innovation through AI and machine learning.
This meeting opens the door to future projects that advance early detection technologies for high-risk diseases, aligning both companies’ missions to improve patient care.

2024 | September

AIMS MEDICAL was awarded Best Spanish Oral Communication at the 2024 European Society of Geriatric Medicine (EUGMS) Congress for its study on aspiration pneumonia using artificial intelligence algorithms.
AIMS-OD software improves the detection and diagnosis of aspiration pneumonia in one-third of geriatric patients hospitalized for pneumonia, enabling fast and accurate identification of at-risk patients and improving clinical management.
For more information, you can read the full article [here]

2024 | June

AIMS Medical receives the grant of the Generalitat de Catalunya for the incorporation of Catalan in technological products.

2024 | February

AIMS Medical S.L. proudly showcased its cutting-edge innovations at the 4YFN (4 Years From Now) event, held in February 2024. Located at Stand 8.1C22.2B, the team, led by Alberto Martín and Cristina Amadó, interacted with visitors on 28th and 29th February.
Our main objectives in attending 4YFN included increasing our company’s visibility, connecting with other leading companies in the sector, observing the latest technological trends and continuously learning on both a personal and professional level.
For more information, you can read the full article [here]

2024 | January

We have been selected by the Association of Science and Technology Parks of Spain (APTE) as one of the 100 best startups of 2023.

2023 | November

On 9 November, the AIMS MEDICAL team, located in the Tecnocampus incubator, played a leading role in the PECT Mataró-Maresme Research Conference, which was successfully held at the Tecnocampus in Mataró.
Adil El Haji led an information stand where visitors had the opportunity to understand in depth the company’s functions, meet its dedicated team and identify the problem of under-diagnosis of dysphagia and how AIMS-OD proposes a fast, quality and cost-efficient solution.
AIMS MEDICAL was also represented in two oral communications by two members of our team, Alberto Martín and Cristina Amadó.

2023 | October

The public agency of the Generalitat de Catalunya, Catalonia Trade & Investment, is pleased to announce the incorporation of AIMS Medical to its innovative startup platform, the Barcelona & Catalonia Startup Hub.
Catalonia Trade & Investment, an entity dedicated to boosting foreign investment in the Barcelona region and Catalonia, has added AIMS Medical to its select group of promising companies.

2023 | September

AIMS-Medical has been awarded funding from the “Start-up Capital for Emerging Technology Companies 2023” call by ACCIÓ, a recognition of our commitment to innovation in medical technology.
Our roadmap includes expanding our platform to address other diseases that often go undetected and under-diagnosed, and we are also committed to job creation in key areas such as engineering and biomedicine.
Learn more about what this recognition means for AIMS Medical in our news article [here].

2023 | July

AIMS Medical has been awarded the prestigious Neotec 2023 grant, granted by the Centre for the Development of Industrial Technology (CDTI), with funding of €325.000.
Learn more about what this recognition means for AIMS Medical in our news article [here].

2023 | June

Attendance at the second edition of the TAULÍ HEALTH ARTIFICIAL INTELLIGENCE SYMPOSIUM [THAIS] organised by Parc Taulí Hospital Universitari.

2023 | June

Innovative platform for oropharyngeal dysphagia screening presented at the Unió Catalana d’Hospitals conference.
Positive impact of AI in clinical practice: Health Observatory/IA and AIMS-OD platform at the centre of attention in the health sector.

2023 | June

Best poster award at the congress of the Spanish Society of Clinical Nutrition and Metabolism (SENPE) for our work Improving the screening and diagnosis of elderly patients with oropharyngeal dysphagia in a general hospital using machine learning.
Learn more about what this recognition means for AIMS MEDICAL in our news article [here]

2022 | December

Spanish Patent Granted
Publication of the scientific article “A Systematic and Universal Artificial Intelligence Screening Method for Oropharyngeal Dysphagia: Improving Diagnosis Through Risk Management”.

2022 | October

Product Grant from AGAUR for clinical validation of AIMS-OD with the “Gold Standard” (Videofluoroscopy) and advance to the CE and FDA medical device mark.

2022 | September

Best moderated poster award in Artificial Intelligence and upper-Gi neoplasia in the United European Gastroenterology Congress (Vienna, Austria)

2022 | April

Constitution of AIMS-Medical

2022 | May

Patent application extension to Europe and USA.

2022 | March

Award for the best oral communication in Spanish Society of Gastroenterology Congress (Madrid, Spain)

2021 | November

Creatic award for the best business initiative in the field of technology and innovation (Barcelona, Spain).

2025 | May

AIMS MEDICAL is participating in the Open Innovation Challenge at the Health Revolution Congress, with Neus Giménez representing us in 1-to-1 investor meetings at Recinte Modernista de Sant Pau, Barcelona.
Powered by ACCIÓ and Barcelona Health Hub, the event connects digital health innovation with investment to shape the future of healthcare.

2021 | August

Award for the best oral communication in World Dysphagia Summit (Nagoya,Japan).
Learn more about what this recognition means for AIMS MEDICAL in our news article [here].

2020

StartHealth TecnoCampus. Start-up acceleration program
CaixaImpulse Validate. Start-up acceleration program

2019 | November

Spanish patent application

2018

First AIMS-OD prototype

Ongoing projects

Valorizations projects

CaixaImpulse Validate 2020-2023 (“LaCaixa” Fundation).
Product Grant (Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) – Generalitat Catalunya).

Universal and systematic screening for Oropharyngeal Dysphagia

iNexes CSC: Transformative Projects – CatSalut (Inexes CSC – Projectes transformadors – CatSalut). Oropharyngeal Dysphagia Triage Service to 7 hospitals in 2023-2025.

Corporació de Salut del Maresme i la Selva
Badalona Serveis Assistencials
Serveis de Salut Integrats del Baix Empordà
Consorci Hospitalari de Vic
Sant Andreu Salut
Fundació Privada Hospital Asil de Granollers
Parc Sanitari Pere Virgili

Mataró-Maresme

Innovation Ecosystem for Caring Cities (Mataró-Maresme: Ecosistema d’innovació per a les ciutats cuidadores). Oropharyngeal Dysphagia Triage Service to Mataró Hospital and primary care from Mataró city (>125.000 citizens)